Globally, 296 million people are infected with hepatitis B virus (HBV), and approximately one
million people die annually from HBV-related causes, including liver cancer. Although there …

Abstract Treatment of chronic hepatitis B (CHB) patients with nucleos (t) ide analogs (NAs)
suppresses hepatitis B virus (HBV) DNA synthesis but does not affect synthesis of HBV …

Background: The full spectrum of HIV-1 diversity can be found in Central Africa, including 2
divergent HIV-1 strains collected in 1983 and 1990 in Democratic Republic of Congo (DRC) …

Background and Aims The clinical utility of two biomarkers, hepatitis B virus (HBV) RNA and
hepatitis B core‐related antigen (HBcrAg), as compared to conventional markers of HBV …

Background : Viral diversity presents an ongoing challenge for diagnostic tests, which need
to accurately detect all circulating variants. The Abbott Global Surveillance program monitors …

Background Direct-acting antivirals for chronic hepatitis C (HCV) infection have reduced the
need for on-treatment HCV RNA monitoring. We assessed the accuracy and cost …

While diagnosis of COVID-19 relies on qualitative molecular testing for the absence or
presence of SARS-CoV-2 RNA, quantitative viral load determination for SARS-CoV-2 has many …

Arbovirus infections are frequent causes of acute febrile illness (AFI) in tropical countries.
We conducted health facility-based AFI surveillance at four sites in Colombia (Cucuta, Cali, …

The first 18 months of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infections in Colombia were characterized by three epidemic waves. During the third wave, from …

Metagenomic next-generation sequencing (mNGS) has enabled the high-throughput
multiplexed identification of sequences from microbes of potential medical relevance. This …